[go: up one dir, main page]

TN2011000545A1 - Vinyl indazolyl compounds - Google Patents

Vinyl indazolyl compounds

Info

Publication number
TN2011000545A1
TN2011000545A1 TNP2011000545A TN2011000545A TN2011000545A1 TN 2011000545 A1 TN2011000545 A1 TN 2011000545A1 TN P2011000545 A TNP2011000545 A TN P2011000545A TN 2011000545 A TN2011000545 A TN 2011000545A TN 2011000545 A1 TN2011000545 A1 TN 2011000545A1
Authority
TN
Tunisia
Prior art keywords
vinyl
compounds
indazolyl compounds
vinyl indazolyl
indazoiyl
Prior art date
Application number
TNP2011000545A
Inventor
Daohong Chen
Hong Yu Li
Genshi Zhao
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2010/033487 external-priority patent/WO2010129509A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of TN2011000545A1 publication Critical patent/TN2011000545A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides vinyl indazoiyl compounds useful in the treatment of cancer.
TNP2011000545A 2010-02-04 2011-10-25 Vinyl indazolyl compounds TN2011000545A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30141610P 2010-02-04 2010-02-04
PCT/US2010/033487 WO2010129509A1 (en) 2009-05-07 2010-05-04 Vinyl indazolyl compounds

Publications (1)

Publication Number Publication Date
TN2011000545A1 true TN2011000545A1 (en) 2013-05-24

Family

ID=59787567

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2011000545A TN2011000545A1 (en) 2010-02-04 2011-10-25 Vinyl indazolyl compounds

Country Status (1)

Country Link
TN (1) TN2011000545A1 (en)

Similar Documents

Publication Publication Date Title
MY160390A (en) Vinyl indazolyl compounds
JO2788B1 (en) Amidophenoxyindazoles useful as inhibitors of c-met
MX356525B (en) Aav -vectors for use in gene therapy of choroideremia.
ZA201207574B (en) Phytocannabinoids in the treatment of cancer
EA201400178A1 (en) BREAST CANCER TREATMENT
MY157341A (en) Methods and compositions for treating lung cancer
JO3755B1 (en) Testosterone formulations
MX2014012477A (en) Pyrrolopyrazone inhibitors of tankyrase.
IL238177A0 (en) Methods and compositions for the treatment of cancer
MX2013007268A (en) Bicyclic pkm2 activators.
SI2605764T1 (en) Compositions for the treatment of cancer
ZA201300762B (en) Novel combination therapy for the treatment of cancer
IN2014DN00254A (en)
UA117567C2 (en) Galactagogue compositions based on phosphatidylserine
PH12013501115A1 (en) Oxazolo [5, 4 -b] pyridin- 5 -yl compounds and their use for the treatment of cancer
GB201718726D0 (en) Phytocannabinoids in the treatment of cancer
TN2011000545A1 (en) Vinyl indazolyl compounds
WO2012037553A9 (en) Use of pkc-iota inhibitors for the treatment of breast cancer
MY159995A (en) Pyrimidinyl indole compounds
TN2011000013A1 (en) Amidophenoxyindazoles useful as inhibitors of c-met
UA101379C2 (en) Amidophenoxyindazoles useful in the treatment of cancer
UA58160U (en) use of Lipoflavon for treatment of cerebrovascular trauma
UA72478U (en) Use of polentar as frigoprotector
CY1114071T1 (en) Vinylindazolyl compounds
MX2015001134A (en) Therapeutic compounds.